Enovis Corp (ENOV) PT Lowered to $50 at UBS, Estimates Updated

UBS analyst Danielle Antalffy lowered the price target on Enovis Corp (NYSE: ENOV) to $50.00 (from $57.00) while maintaining a Buy rating.

The analyst commented, "We updated our ENOV estimates to reflect management intra-quarter commentary. Our model now reflects sales of $2,261/$2,374/$2,520 in '25/'26/'27 (vs $2,266/$2,409/$2,570 prior) which trickles down to adjusted EPS of $3.20/$3.55/$4.05 (vs $3.20/$3.60/$4.20 prior) over the same timeframe. These changes move our price target to $50 (from $57 previously) on an unchanged ~2x NTM EV/Sales multiple. Regardless, we continue to see stable P&R growth and HSD Recon growth with more contribution from new and ramping product launches, namely ARVIS in 1H26, as focal points that serve as drivers of growth acceleration from here. We'd also reiterate our confidence in ENOV's operating leverage capabilities as well as growing cash flow generation."

You May Also Be Interested In

• Lake Street Starts RF Industries Ltd. (RFIL) at Buy
• Coherent (COHR) PT Raised to $420 at Needham
• Burry doubles down on Nebius short after stock surges 34% on earnings